waypoint wealth counsel »

United Therapeutics Corporation shares owned by waypoint wealth counsel

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by waypoint wealth counsel from 13F filings

Historical chart of waypoint wealth counsel investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by waypoint wealth counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by waypoint wealth counsel

Quarter filed Position value Share count Share price at filing
2025-12-31 $342k 701 487.25

More positions owned by waypoint wealth counsel

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Whitehall Fds High Div Yld (VYM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Coca-Cola Company (KO)
Microsoft Corporation (MSFT)
Ishares Gold Tr Ishares New (IAU)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Small Cp Etf (VB)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for waypoint wealth counsel

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation